Home
/
Alto Ingredients, Inc.
/
Financials
/
Quarterly
Alto Ingredients, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Alto Ingredients, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$240.99M
Nov 7, 2025
Q2
2025
Jun 30, 2025
$218.44M
Aug 8, 2025
Q1
2025
Mar 31, 2025
$226.54M
May 9, 2025
Q3
2025
Sep 30, 2024
$251.81M
Nov 7, 2025
Q2
2025
Jun 30, 2024
$236.47M
Aug 8, 2025
Q1
2025
Mar 31, 2024
$240.63M
May 9, 2025
Q3
2024
Sep 30, 2023
$318.13M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$317.30M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$313.89M
May 8, 2024
Q3
2023
Sep 30, 2022
$336.88M
Nov 8, 2023
Q2
2023
Jun 30, 2022
$362.19M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$308.12M
May 9, 2023
Q3
2022
Sep 30, 2021
$305.56M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$298.11M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$218.73M
May 10, 2022
Q1
2016
Mar 31, 2016
$342.37M
May 9, 2016
Q1
2016
Mar 31, 2015
$206.18M
May 9, 2016
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$400.03M
May 10, 2018
Q3
2017
Sep 30, 2017
$445.44M
Nov 9, 2017
Q2
2017
Jun 30, 2017
$405.20M
Aug 9, 2017
Q1
2018
Mar 31, 2017
$386.34M
May 10, 2018
Q3
2017
Sep 30, 2016
$417.81M
Nov 9, 2017
Q2
2017
Jun 30, 2016
$422.86M
Aug 9, 2017
Q1
2017
Mar 31, 2016
$342.37M
May 10, 2017
Q3
2016
Sep 30, 2015
$380.62M
Nov 8, 2016
Q2
2016
Jun 30, 2015
$227.62M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$206.18M
May 9, 2016
Q3
2015
Sep 30, 2014
$275.57M
Nov 6, 2015
Q2
2015
Jun 30, 2014
$321.14M
Aug 10, 2015
Q1
2015
Mar 31, 2014
$254.54M
May 11, 2015
Q3
2014
Sep 30, 2013
$233.88M
Nov 12, 2014
Q2
2014
Jun 30, 2013
$233.81M
Aug 14, 2014
Q1
2014
Mar 31, 2013
$225.46M
May 9, 2014
Q3
2013
Sep 30, 2012
$215.86M
Nov 12, 2013
Q2
2013
Jun 30, 2012
$205.45M
Aug 7, 2013
Q1
2013
Mar 31, 2012
$197.72M
May 15, 2013
Q3
2012
Sep 30, 2011
$271.65M
Nov 14, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$14.21M
Nov 7, 2025
Q2
2025
Jun 30, 2025
($11.00M)
Aug 8, 2025
Q3
2025
Jun 30, 2025
($11.00M)
Nov 7, 2025
Q1
2025
Mar 31, 2025
($11.68M)
May 9, 2025
Q2
2025
Mar 31, 2025
($11.68M)
Aug 8, 2025
Q3
2025
Mar 31, 2025
($11.68M)
Nov 7, 2025
Q3
2025
Sep 30, 2024
($2.44M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($3.11M)
Aug 8, 2025
Q3
2025
Jun 30, 2024
($3.11M)
Nov 7, 2025
Q2
2025
Mar 31, 2024
($11.73M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($11.73M)
May 9, 2025
Q3
2025
Mar 31, 2024
($11.73M)
Nov 7, 2025
Q3
2024
Sep 30, 2023
($3.49M)
Nov 8, 2024
Q3
2024
Jun 30, 2023
$7.60M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$7.60M
Aug 8, 2024
Q2
2024
Mar 31, 2023
($13.17M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($13.17M)
May 8, 2024
Q3
2024
Mar 31, 2023
($13.17M)
Nov 8, 2024
Q3
2023
Sep 30, 2022
($28.04M)
Nov 8, 2023
Q3
2023
Jun 30, 2022
$22.12M
Nov 8, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$16.98M
Nov 7, 2025
Q2
2025
Jun 30, 2025
($8.11M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($9.00M)
May 9, 2025
Q3
2025
Sep 30, 2024
($720.0K)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($1.41M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($10.33M)
May 9, 2025
Q3
2024
Sep 30, 2023
($4.33M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
$9.27M
Aug 8, 2024
Q1
2024
Mar 31, 2023
($11.62M)
May 8, 2024
Q3
2023
Sep 30, 2022
($27.24M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($152.0K)
Aug 8, 2023
Q1
2023
Mar 31, 2022
($2.86M)
May 9, 2023
Q3
2022
Sep 30, 2021
($8.93M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
$6.10M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$5.62M
May 10, 2022
Q3
2021
Sep 30, 2020
$26.28M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$22.55M
Aug 10, 2021
Q1
2021
Mar 31, 2020
($23.10M)
May 17, 2021
Q3
2020
Sep 30, 2019
($23.50M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($2.74M)
Aug 13, 2020